With Great Sorrow We Announce the Passing of Prof. Parttaporn Isarangkura: A Pioneer in Hemophilia Care in Thailand and Beyond
Brian O Mahony, CEO of Irish Haemophilia Society, has shared a devastating news announcement about Parttaporn Isarangkura on X:
”It was with deep sadness that I learned today of the passing of Prof. Parttaporn Isarangkura from Bangkok, Thailand. Dr. Pat as we referred to her was a very renowned and major figure in the medical and bleeding disorders community in Thailand – WFH.”
It is with great regret that we announce the passing of Professor Parttaporn Isarangkura, a visionary leader who transformed hemophilia care in Thailand—introducing platelet concentrates for dengue fever, cryoprecipitate for hemophilia, and spearheading HIV antigen testing.
As national lead for hemophilia services, she implemented strategic, lasting improvements with grace, determination, and quiet strength.
A mentor across ASEAN and a key figure in the success of the 2004 WFH Global Congress in Thailand, Dr. Pat’s legacy is one of diplomacy, impact, and unwavering dedication.
The latest news in the field of bleeding and thrombosis featured in Hemostasis Today.
-
Oct 9, 2026, 11:51Sumaiya Dickens: Marginal Zone B Cells in Transfusion Medicine and Hemophilia A Research
-
Oct 9, 2026, 11:44Ayyappan V Nair: PRP and Rehabilitation – Can It Help Athletes with Partial Rotator Cuff Tears?
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number